Dashboard
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Poor long term growth as Net Sales has grown by an annual rate of -24.13% and Operating profit at -209.06% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Risky -
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
26.0%
0%
26.0%
6 Months
89.76%
0%
89.76%
1 Year
221.43%
0%
221.43%
2 Years
142.31%
0%
142.31%
3 Years
632.56%
0%
632.56%
4 Years
-93.0%
0%
-93.0%
5 Years
-93.19%
0%
-93.19%
Sinopharm Tech Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-24.13%
EBIT Growth (5y)
-209.06%
EBIT to Interest (avg)
-3.76
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
-2.44
Tax Ratio
1.54%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.52%
ROE (avg)
1.98%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-15.71
EV to EBIT
-1.88
EV to EBITDA
-2.04
EV to Capital Employed
-19.42
EV to Sales
8.39
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'17 - YoY
Jun'17
Jun'16
Change(%)
Net Sales
3.10
9.20
-66.30%
Operating Profit (PBDIT) excl Other Income
-53.30
-75.50
29.40%
Interest
2.10
3.10
-32.26%
Exceptional Items
-53.80
-85.00
36.71%
Consolidate Net Profit
-108.90
-157.70
30.94%
Operating Profit Margin (Excl OI)
-17,985.70%
-8,437.20%
-954.85%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2017 is -66.30% vs 557.14% in Jun 2016
Consolidated Net Profit
YoY Growth in quarter ended Jun 2017 is 30.94% vs -541.06% in Jun 2016
Annual Results Snapshot (Consolidated) - Jun'24
Jun'24
Jun'23
Change(%)
Net Sales
41.30
42.80
-3.50%
Operating Profit (PBDIT) excl Other Income
-10.30
-88.80
88.40%
Interest
23.90
8.60
177.91%
Exceptional Items
-3.30
14.40
-122.92%
Consolidate Net Profit
-20.40
-9.50
-114.74%
Operating Profit Margin (Excl OI)
-282.50%
-2,119.10%
183.66%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2024 is -3.50% vs 4.39% in Jun 2023
Consolidated Net Profit
YoY Growth in year ended Jun 2024 is -114.74% vs 89.87% in Jun 2023
About Sinopharm Tech Holdings Ltd. 
Sinopharm Tech Holdings Ltd.
Media & Entertainment
No Details Available.
Company Coordinates 
No Company Details Available






